Answers are grounded in this paper and cite their sources.
A melanotic clone of the B16 melanoma was treated with different doses of cyclic AMP, dibutyryl cyclic AMP, and two phosphodiesterase inhibitors, caffeine and theophylline. At nontoxic doses, all agents retarded cellular replication, enhanced melanogenesis, and produced morphologic altertions, i.e., cellular hypertrophy and exaggerated dendrite formation. The results are consistent with the hypothesis that cyclic AMP is a potent regulator of melanoma cellular replication and differentiation.
No takes yet. Share an insight, caveat, or question.
Kreider et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: